GlassScriptPhysician profile
Amanda C Lombardo
NPI 1700251717
$995.96
in general payments reported to CMS, 2019-2025
11 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.27 · 2022: $28.08 · 2023: $134 · 2024: $338 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $439.49 | 2023-2025 | Yescarta |
| Sanofi-Aventis U.S. LLC | $135.95 | 2023-2025 | |
| Abbvie INC. | $121.95 | 2025 | |
| Celgene Corporation | $93.14 | 2022-2024 | Reblozyl |
| Janssen Biotech, INC. | $83.89 | 2021-2024 | Carvykti |
| Acrotech Biopharma INC. | $23.27 | 2025 | Beleodaq |
| Takeda Pharmaceuticals U.S.A., INC. | $21.87 | 2024 | Livtencity |
| Pfizer INC. | $20.32 | 2025 | |
| Abbott Laboratories | $20.29 | 2024 | Cardiomems |
| Rigel Pharmaceuticals, INC. | $19.34 | 2024 | Rezlidhia, Tavalisse |
| Karyopharm Therapeutics INC. | $16.45 | 2024 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lombardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.